2024-01-17 REL RCSB RCSB RCSB 2021-12-05 2022-09-07 2022-09-07 2024-01-17 National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) United States SARS-CoV-2 VFLIP spike boung to 2 Ab12 Fab fragments Olmedillas E Ollmann-Saphire E SARS-CoV-2, spike, VFLIP, Ab12, VIRAL PROTEIN Chang MR Tomasovic L Kuzmina NA Ronk AJ Byrne PO Johnson R Storm N Olmedillas E Hou YJ Schafer A Leist SR Tse LV Ke H Coherd C Nguyen K Kamkaew M Honko A Zhu Q Alter G Saphire EO McLellan JS Griffiths A Baric RS Bukreyev A Marasco WA IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern. Nat Commun UK 13 5814 5814 2022 36192374 doi:10.1038/s41467-022-33030-4 2041-1723 SARS-CoV-2 VFLIP spike boung to 2 Ab12 Fab fragments SARS-CoV-2 VFLIP spike boung to 2 Ab12 Fab fragments 0 Cell-free gateway cloning vector C-term 8xHis pCellFree_G02 singleParticle particle 1.5 7.5 ETHANE FEI TITAN KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 1.2 5.0 FEI FALCON I (4k x 4k) 50.0 1 4.6 FSC 0.143 CUT-OFF 150352 NOT APPLICABLE NOT APPLICABLE emd_25618.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 256 256 256 0 0 0 256 256 256 168.96 168.96 168.96 90.0 90.0 90.0 X Y Z -0.32274494 0.8282887 -0.00026058228 0.03434518 0.66 0.66 0.66 0.133 AUTHOR SARS-CoV-2 VFLIP spike boung to 2 Ab12 Fab fragments